Glioblastoma Corticosteroids Draw Fresh Scrutiny in JCO Commentary
JCO commentary revisits 65 years of corticosteroid use in glioblastoma, questioning routine reliance on dexamethasone and its neurological tradeoffs.
This section contains the website’s posts.